SCHEMBL21614744

SCHEMBL21614744

FC(F)(F)c1cc(SCc2ccc(-c3ccc(Cl)nc3)cn2)ccn1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 3/20 0.36
▸ HDAC6 Q9UBN7 3/20 0.36
▸ HDAC5 Q9UQL6 2/20 0.36
▸ CYP2A6 P11509 1/20 0.35
▸ LOXL2 Q9Y4K0 2/20 0.35
▸ PIK3CD O00329 2/20 0.34
▸ LOX P28300 1/20 0.34
▸ SMARCA2 P51531 1/20 0.34
▸ SMARCA4 P51532 1/20 0.34
▸ DAO P14920 1/20 0.33
▸ IDO1 P14902 1/20 0.33
▸ AKR1C3 P42330 1/20 0.33
▸ AKR1C2 P52895 1/20 0.33
▸ TYMS P04818 2/20 0.32
▸ CYP2C9 P11712 2/20 0.32
▸ CYP2C19 P33261 2/20 0.32
▸ NOTUM Q6P988 1/20 0.31
▸ ALOX5AP P20292 1/20 0.31
▸ FEN1 P39748 1/20 0.31
▸ METAP2 P50579 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21614743 0.90 DAO (0.38) LOXL2LOXDAOIDO1
SCHEMBL21614746 0.90 LOXL2 (0.35) LOXL2PIK3CDLOXSMARCA2SMARCA4
SCHEMBL21611963 0.88 LOXL2 (0.38) CYP2A6LOXL2PIK3CDLOXSMARCA2
SCHEMBL21611924 0.82 CDK2 (0.38) HDAC1HDAC6HDAC5CYP2C9CYP2C19
SCHEMBL21611925 0.81 CYP3A4 (0.41) LOXL2LOXCYP2C19ALOX5APFEN1
SCHEMBL21611945 0.80 LOXL2 (0.38) LOXL2LOXDAOIDO1TYMS
SCHEMBL21611938 0.79 LTA4H (0.40) LOXL2LOXCYP2C19ALOX5APFEN1
SCHEMBL21614733 0.76 CYP2C19 (0.46) HDAC1HDAC6SMARCA2SMARCA4CYP2C9
SCHEMBL21611942 0.71 PPARD (0.47) LOXL2LOXCYP2C9CYP2C19
SCHEMBL15454013 0.69 LOXL2 (0.46) LOXL2LOXDAOCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210353606-A1 PqsR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2021-11-18 — — US disclosed
WO-2020007938-A1 PqsR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2020-01-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210353606-A1 PqsR INVERSE AGONISTS QRFPR, P2RY11, QARS1 HDAC1 3152/4885HDAC6 1724/4885HDAC5 2443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback